3rd party ad 
SUPPORTERis ad-free.
SUPPORTERis ad-free.Jennison Health Sciences Equity
Portfolio
Holdings
| Symbol | Name | Country | Sector | Industry | Most recent quarter | % of Total Shares | % of Total Assets | Shares | Book Value | Market Price Value | Fundamental Score | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ALRN.NASDAQ | Aileron Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.986 | 0 | 895.5k | $285.6k | $2.5m |
| |||||||||||||
| ALT.NASDAQ | Altimmune Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.964 | 0.476 | 474.9k | $1.1m | $3.1m |
| |||||||||||||
| APLS.NASDAQ | Apellis Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.951 | 3.677 | 1.1m | $2.5m | $41.8m |
| |||||||||||||
| ARQT.NASDAQ | Arcutis Biotherapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 2.928 | 1.821 | 3.3m | $6.5m | $35.5m |
| |||||||||||||
| CABA.NASDAQ | Cabaletta Bio Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.812 | 0.362 | 391.8k | $1.7m | $2.7m |
| |||||||||||||
| CBAY.NASDAQ | CBAY.NASDAQ | - | - | - | - | 1.064 | 1.766 | 1.2m | - | - | ||||||||||||||
| CLDX.NASDAQ | Celldex Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.811 | 0.687 | 379.4k | $4.8m | $13.4m |
| |||||||||||||
| CNMD.NYSE | CONMED Corporation | USA | Healthcare | Medical Devices | 2024-03-31 | 0.842 | 1.684 | 257.4k | $7m | $17.7m |
| |||||||||||||
| CRNX.NASDAQ | Crinetics Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 1.032 | 2.064 | 813.5k | $9m | $35.6m |
| |||||||||||||
| DYN.NASDAQ | Dyne Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.666 | 1.019 | 662.2k | $3.1m | $22.7m |
| |||||||||||||
| EYPT.NASDAQ | Eyepoint Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 1.324 | 0.919 | 649.1k | $3m | $5.5m |
| |||||||||||||
| GLPG.NASDAQ | Galapagos NV ADR | USA | Healthcare | Biotechnology | 2024-03-31 | 0.339 | 0.743 | 222.5k | $10.6m | $5.5m |
| |||||||||||||
| IMGN.NASDAQ | IMGN.NASDAQ | - | - | - | - | 0.979 | 0.669 | 2.2m | - | - | ||||||||||||||
| INMD.NASDAQ | InMode Ltd | USA | Healthcare | Medical Devices | 2024-03-31 | 0.414 | 0.475 | 348.5k | $3.3m | $6m |
| |||||||||||||
| KRYS.NASDAQ | KRYS.NASDAQ | - | - | - | - | 0.602 | 1.658 | 171.9k | - | - | ||||||||||||||
| LBPH.NASDAQ | Longboard Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.87 | 0.396 | 338.1k | $3m | $11.7m |
| |||||||||||||
| MCRB.NASDAQ | Seres Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.639 | 0.233 | 818.6k | -$322.5k | $664.7k |
| |||||||||||||
| MDGL.NASDAQ | Madrigal Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.435 | 0.311 | 74.3k | $2.9m | $20.5m |
| |||||||||||||
| MRNS.NASDAQ | Marinus Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 3.143 | 0.846 | 1.7m | -$498.9k | $2m |
| |||||||||||||
| MRUS.NASDAQ | Merus BV | USA | Healthcare | Biotechnology | 2024-03-31 | 0.341 | 0.212 | 156.3k | $810.8k | $8.3m |
| |||||||||||||
| MRVI.NASDAQ | Maravai Lifesciences Holdings Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.99 | 0.845 | 1.3m | $7.6m | $9.1m |
| |||||||||||||
| NVO.NYSE | Novo Nordisk A/S | USA | Healthcare | Biotechnology | 2024-03-31 | 0.03 | 4.581 | 687.1k | $2.2m | $97.8m |
| |||||||||||||
| PHAT.NASDAQ | Phathom Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 1.524 | 0.514 | 892.2k | -$2.2m | $9.1m |
| |||||||||||||
| PHR.NYSE | Phreesia Inc | USA | Healthcare | Health Information Services | 2024-04-30 | 1.036 | 0.695 | 576.1k | $2.5m | $11.6m |
| |||||||||||||
| PLRX.NASDAQ | Pliant Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.587 | 0.404 | 343.2k | $2.4m | $3.6m |
| |||||||||||||
| PTGX.NASDAQ | Protagonist Therapeutics Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.504 | 0.418 | 288.3k | $2.5m | $9.7m |
| |||||||||||||
| SNDX.NASDAQ | Syndax Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.824 | 0.538 | 573.8k | $3.3m | $12m |
| |||||||||||||
| SVRA.NASDAQ | Savara Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 4.04 | 1.507 | 5.5m | $3.7m | $24.7m |
| |||||||||||||
| TARS.NASDAQ | Tarsus Pharmaceuticals Inc | USA | Healthcare | Biotechnology | 2024-03-31 | 0.659 | 0.49 | 248.8k | $1.8m | $6.9m |
| |||||||||||||
| VRNA.NASDAQ | Verona Pharma PLC ADR | USA | Healthcare | Biotechnology | 2024-03-31 | 0.862 | 0.61 | 699.2k | $1.9m | $11.2m |
|
Trades
Buys
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| DYN.NASDAQ | 662.2k | - | 14.9m | 12-30 | $34.40 | 179.0% |
| LBPH.NASDAQ | 338.1k | - | 7.3m | 16-28 | $34.87 | 115.2% |
| PHAT.NASDAQ | 892.2k | - | 7.5m | 6-11 | $10.30 | 69.8% |
| TARS.NASDAQ | 248.8k | - | 7.3m | 19-40 | $27.88 | 46.8% |
Report date: 2023-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| EYPT.NASDAQ | 649.1k | - | 7.2m | 6-25 | $8.49 | 49.7% |
| INMD.NASDAQ | 348.5k | - | 7.8m | 19-31 | $17.37 | -6.5% |
Report date: 2023-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| MRNS.NASDAQ | 1.2m | - | 10.7m | 6-11 | $1.20 | -81.2% |
| SVRA.NASDAQ | 1.6m | - | 3.9m | 2-3 | $4.43 | 171.8% |
Report date: 2023-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CABA.NASDAQ | 523.8k | - | 4.9m | 6-13 | $7.05 | 19.9% |
| CBAY.NASDAQ | 405.8k | - | 3.2m | 6-10 | - | - |
| PTGX.NASDAQ | 288.3k | - | 4.8m | 11-26 | $33.72 | 217.5% |
Report date: 2022-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ALT.NASDAQ | 474.9k | - | 5.3m | 8-17 | $6.62 | -20.1% |
| VRNA.NASDAQ | 699.2k | - | 9.3m | 9-26 | $16.11 | 74.0% |
Report date: 2022-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CLDX.NASDAQ | 379.4k | - | 11.6m | 22-39 | $35.50 | 64.0% |
| IMGN.NASDAQ | 2.2m | - | 11.6m | 4-7 | - | - |
| PLRX.NASDAQ | 343.2k | - | 6.5m | 7-25 | $10.52 | 41.4% |
| SNDX.NASDAQ | 573.8k | - | 12.8m | 18-26 | $20.93 | 16.0% |
Report date: 2022-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ALRN.NASDAQ | 895.5k | - | 412.3k | 0-1 | $2.87 | 1,034.4% |
| APLS.NASDAQ | 874.6k | - | 40m | 33-60 | $36.24 | 8.8% |
| GLPG.NASDAQ | 222.5k | - | 13.2m | 52-72 | $25.09 | -51.7% |
| MDGL.NASDAQ | 115.9k | - | 8.6m | 57-106 | $276.55 | 383.9% |
| MRUS.NASDAQ | 156.3k | - | 3.2m | 13-30 | $53.34 | 296.1% |
| NVO.NYSE | 687.1k | - | 76.2m | 102-122 | $142.37 | 39.4% |
Adds
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| CRNX.NASDAQ | 138.7k | 20.6 | 5.4m | 34-48 | $43.83 | 30.2% |
Report date: 2023-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ARQT.NASDAQ | 1.8m | 119.3 | 5m | 2-5 | $10.49 | 496.0% |
| KRYS.NASDAQ | 9k | 4.6 | 1m | 94-130 | - | - |
| SVRA.NASDAQ | 3.2m | 139.1 | 12.4m | 3-5 | $4.43 | 42.2% |
Report date: 2023-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| APLS.NASDAQ | 744.4k | 85.1 | 33.2m | 20-92 | $36.24 | 82.8% |
| CABA.NASDAQ | 94.8k | 11.7 | 1.2m | 12-19 | $7.05 | -39.4% |
| CBAY.NASDAQ | 368.4k | 32.8 | 4.8m | 10-18 | - | - |
| CRNX.NASDAQ | 379.6k | 128.6 | 7.8m | 16-31 | $43.83 | 178.1% |
| KRYS.NASDAQ | 159.3k | 409.4 | 19.4m | 107-133 | - | - |
| MRNS.NASDAQ | 466.3k | 37.0 | 3.8m | 6-11 | $1.20 | -79.3% |
| MRVI.NASDAQ | 206k | 18.7 | 2.2m | 9-13 | $6.99 | -23.1% |
| SVRA.NASDAQ | 646.7k | 38.3 | 2.3m | 3-4 | $4.43 | 60.8% |
Report date: 2023-06-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ARQT.NASDAQ | 793.3k | 105.5 | 8.8m | 7-15 | $10.49 | 44.7% |
| CABA.NASDAQ | 289.3k | 55.2 | 3.1m | 7-14 | $7.05 | 1.6% |
| CBAY.NASDAQ | 716.8k | 176.6 | 6.6m | 7-11 | - | - |
| MCRB.NASDAQ | 450.4k | 122.3 | 2.4m | 5-7 | $0.81 | -82.0% |
Report date: 2023-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| ARQT.NASDAQ | 319.5k | 73.9 | 4.6m | 10-18 | $10.49 | 4.4% |
| PHR.NYSE | 39.8k | 7.4 | 1.4m | 30-40 | $20.15 | -32.8% |
Report date: 2022-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| PHR.NYSE | 33.4k | 6.7 | 908.8k | 22-36 | $20.15 | -8.2% |
Report date: 2022-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| PHR.NYSE | 227.4k | 82.6 | 5.6m | 22-30 | $20.15 | -7.0% |
Reduces
Report date: 2024-03-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| APLS.NASDAQ | -55.8k | -4.6 | -3.5m | 53-74 | $36.24 | -31.9% |
| KRYS.NASDAQ | -35.5k | -17.1 | -4.9m | 108-190 | - | - |
Report date: 2023-12-31
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| APLS.NASDAQ | -409.2k | -25.3 | -20.7m | 36-66 | $36.24 | -0.2% |
| CABA.NASDAQ | -516.2k | -56.9 | -8.6m | 10-24 | $7.05 | -26.2% |
| CBAY.NASDAQ | -270.4k | -18.1 | -4.8m | 12-25 | - | - |
Report date: 2022-09-30
| Trade | Current | |||||
|---|---|---|---|---|---|---|
| Symbol | Shares | % | Total | $ Range | Price | % |
| MDGL.NASDAQ | -41.5k | -35.9 | -2.8m | 59-82 | $276.55 | 365.0% |